Intercept Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
144,910.00
239,723.80
628,055.00
689,385.00
414,917.00
436,160
Total Accounts Receivable
1,378.00
2,557.00
3,691.00
12,335.00
18,572.00
25,694
Other Current Assets
1,276.60
3,547.00
9,947.00
6,145.00
14,818.00
20,571
Total Current Assets
147,564.50
245,827.80
641,693.00
707,865.00
448,307.00
482,425
Net Property, Plant & Equipment
1,672.30
5,851.80
10,047.00
11,295.00
16,184.00
10,411
Total Investments and Advances
-
2,469.30
4,018.00
-
-
-
Other Assets
1,081.80
-
-
20,093.00
19,856.00
16,331
Total Assets
150,318.60
254,148.90
655,758.00
739,253.00
484,347.00
509,167
Accounts Payable
3,196.00
3,129.00
4,170.00
6,722.00
6,965.00
Other Current Liabilities
5,685.40
12,112.10
43,203.00
71,790.00
97,069.00
Total Current Liabilities
8,881.40
15,241.10
47,373.00
78,512.00
104,034.00
Long-Term Debt
-
-
-
341,356.00
355,677.00
Other Liabilities
59,031.10
8,017.30
6,236.00
4,453.00
8,250.00
Total Liabilities
67,912.50
23,258.40
53,609.00
424,321.00
467,961.00
Common Equity (Total)
82,406.10
230,890.50
602,149.00
314,932.00
16,386.00
Total Shareholders' Equity
82,406.10
230,890.50
602,149.00
314,932.00
16,386.00
Total Equity
82,406.10
230,890.50
602,149.00
314,932.00
16,386.00
Liabilities & Shareholders' Equity
150,318.60
254,148.90
655,758.00
739,253.00
484,347.00
About Intercept Pharmaceuticals
View Profile
